Inventionmed SA
WSE:INM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Inventionmed SA
WSE:INM
|
PL |
|
T
|
Thyrocare Technologies Ltd
BSE:539871
|
IN |
|
I
|
Ice Code Games SA
WSE:ICG
|
PL |
|
Mersana Therapeutics Inc
NASDAQ:MRSN
|
US |
|
Seria Co Ltd
TSE:2782
|
JP |
|
Takkt AG
XETRA:TTK
|
DE |
|
SITC International Holdings Co Ltd
HKEX:1308
|
HK |
|
JCHX Mining Management Co Ltd
SSE:603979
|
CN |
|
Orsted A/S
OTC:DNNGY
|
DK |
|
Kyodo Printing Co Ltd
TSE:7914
|
JP |
|
Bonheur ASA
OSE:BONHR
|
NO |
|
Polaris Holdings Co Ltd
TSE:3010
|
JP |
Balance Sheet
Balance Sheet Decomposition
Inventionmed SA
Inventionmed SA
Balance Sheet
Inventionmed SA
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
10
|
6
|
3
|
3
|
1
|
6
|
4
|
0
|
0
|
|
| Cash |
0
|
0
|
1
|
2
|
2
|
1
|
0
|
1
|
6
|
4
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
9
|
4
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
6
|
3
|
1
|
1
|
0
|
2
|
4
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
6
|
3
|
1
|
0
|
0
|
2
|
4
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
4
|
0
|
0
|
11
|
12
|
6
|
13
|
2
|
6
|
6
|
4
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
14
|
28
|
28
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
8
|
0
|
27
|
31
|
10
|
10
|
9
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
0
N/A
|
0
N/A
|
12
N/A
|
14
+18%
|
14
+2%
|
13
-5%
|
32
+141%
|
44
+36%
|
30
-30%
|
43
+41%
|
38
-12%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
10
|
15
|
15
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
2
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
0
|
1
|
3
|
0
|
1
|
1
|
10
|
14
|
17
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
7
|
17
|
19
|
|
| Total Liabilities |
2
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
3
+199%
|
0
-94%
|
1
+324%
|
1
+119%
|
14
+837%
|
23
+65%
|
37
+64%
|
36
-2%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
10
|
10
|
14
|
14
|
20
|
20
|
20
|
20
|
20
|
|
| Retained Earnings |
1
|
0
|
0
|
1
|
0
|
2
|
3
|
10
|
10
|
12
|
14
|
19
|
|
| Additional Paid In Capital |
1
|
0
|
0
|
1
|
1
|
1
|
1
|
14
|
14
|
14
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
0
N/A
|
0
N/A
|
11
N/A
|
11
+3%
|
14
+25%
|
13
-9%
|
31
+142%
|
30
-2%
|
8
-74%
|
6
-24%
|
2
-74%
|
|
| Total Liabilities & Equity |
4
N/A
|
0
N/A
|
0
N/A
|
12
N/A
|
14
+18%
|
14
+2%
|
13
-5%
|
32
+141%
|
44
+36%
|
30
-30%
|
43
+41%
|
38
-12%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
1
|
0
|
0
|
112
|
112
|
156
|
156
|
221
|
221
|
203
|
203
|
203
|
|